These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13581049)

  • 1. Chemical nature of toxohormone (Nakahara). II. The KIK factor (V) from cancerous urine and the corresponding component of normal urine act as toxohormones.
    MASAMUNE H; KAKETA H; ABE S
    Tohoku J Exp Med; 1958 Apr; 67(4):329-33. PubMed ID: 13581049
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical nature of toxohormone (Nakahara). 3. KIK-in-active toxohormones from urines, cancerous and normal.
    MASAMUNE H; HAKOMORI S; KAKETA H; SINOHARA H; ABE S
    Tohoku J Exp Med; 1958 Jun; 68(1):63-73. PubMed ID: 13592847
    [No Abstract]   [Full Text] [Related]  

  • 3. A KIK factor from cancerous urine and the corresponding fraction of normal urine act as Nakahara toxohormones; preliminary note.
    MASAMUNE H; KAKETA H; ABE S
    Tohoku J Exp Med; 1957 Dec; 67(1):42. PubMed ID: 13529960
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical studies of carbohydrates. CCXI. A KIK factor (V) from cancerous urine and the corresponding substance from normal urine.
    KAKETA H
    Tohoku J Exp Med; 1958 Apr; 67(4):319-28. PubMed ID: 13581048
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical studies on carbohydrates. CLXXXVIII. Chemical nature of KIK factors. II. KIK factor in cancerous ascitic fluid.
    SUGIMOTO K
    Tohoku J Exp Med; 1956 Oct; 64(3-4):271-80. PubMed ID: 13401425
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical nature of toxohormone (Nakahara). VI. The group mucopolysaccharide from pig stomach mucus acts as a weak toxohormone.
    MASAMUNE H; SINOHARA H; ABE S; KAKETA H
    Tohoku J Exp Med; 1958 Dec; 69(1):53-7. PubMed ID: 13659520
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical nature of toxohormone (Nakahara). I. A globulin-like toxohormone from cancerous ascitic fluid (A.P.I.).
    MASAMUNE H; TSUIKI S; KAMIYAMA S; ABE S; HAGA M; KAWASAKI H; KAKETA H; ABE S
    Tohoku J Exp Med; 1958 Apr; 67(4):309-18. PubMed ID: 13581047
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxohormones without KIK-potency from urines, cancerous and normal; preliminary note.
    MASAMUNE H; HAKOMORI S; KAKETA H; ABE S
    Tohoku J Exp Med; 1958 Apr; 67(4):334. PubMed ID: 13581050
    [No Abstract]   [Full Text] [Related]  

  • 9. On the fractionation of toxohormone-like principle in cancerous urine extract.
    Okada K
    Sapporo Igaku Zasshi; 1965 Sep; 28(3):234-52. PubMed ID: 5895805
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical studies on carbohydrates. CCVII. Dialyzable KIK factor in cancerous ascitic fluid.
    HAGA M
    Tohoku J Exp Med; 1957 Dec; 67(1):43-54. PubMed ID: 13529961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of catalase in vitro by extracts of urine of normal and cancerous subjects].
    LOBO LG
    Arq Bras Med; 1957; 47(5-6):193-200. PubMed ID: 13459770
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
    Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
    Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of toxohormone; a seventh study on toxohormone, the characteristic toxic substance produced by cancer tissue.
    NAKAHARA W; FUKUOKA F
    Gan; 1954 Mar; 45(1):77-85. PubMed ID: 13183270
    [No Abstract]   [Full Text] [Related]  

  • 14. Dialyzable form of toxohormone: a sixth study on toxohormone, a characteristic toxic substance produced by cancer tissue.
    NAKAHARA W; FUKUOKA F
    Gan; 1954 Mar; 45(1):67-75. PubMed ID: 13183269
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of temperature on surface properties of cervical tissue homogenate and organic phase monolayers.
    Preetha A; Banerjee R; Huilgol N
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):12-8. PubMed ID: 17628449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of toxohormone function. II.
    HOSHIZIMA H
    Gan; 1958 Sep; 49(3):171-6. PubMed ID: 13609802
    [No Abstract]   [Full Text] [Related]  

  • 17. Concerns in reporting of serum vascular endothelial growth factor levels: comment on the article by Nakahara et al.
    Ferrero S
    Arthritis Rheum; 2004 Jun; 50(6):2037. PubMed ID: 15188386
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tensiometric profiles and their modulation by cholesterol: implications in cervical cancer.
    Preetha A; Banerjee R; Huilgol N
    Cancer Invest; 2007; 25(3):172-81. PubMed ID: 17530487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquisition of toxohormone-like activity by serum constituents following certain chemical treatment].
    ONO T; UMEDA M; SUGIMURA T; FUCHIGAMI A
    Gan; 1957 Dec; 48(4):601-2. PubMed ID: 13524526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.